Title : Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson's disease patients: a prospective longitudinal study.

Pub. Date : 2022 Jan

PMID : 34031800






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Safinamide is a new monoamine oxidase B inhibitor, also exerting a non-dopaminergic effect, recently approved as add-on therapy in fluctuating PD patients. safinamide monoamine oxidase B Homo sapiens